Form 4: Codexis Director Raymond De Vre Sells Shares
Statement of Changes in Beneficial Ownership
Director Raymond De Vre sold 2,605 shares of Codexis, Inc. to cover tax obligations related to RSU vesting.
Summary
- Director Raymond De Vre sold 2,605 shares of Codexis, Inc. (CDXS) common stock on June 11, 2026.
- The shares were sold at a price of $2.37 per share.
- The transaction was executed to satisfy tax withholding obligations resulting from the vesting of Restricted Stock Units (RSUs).
- Following this transaction, the reporting person maintains beneficial ownership of 84,811 shares, which includes 31,897 unvested RSUs.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was purely administrative to cover tax liabilities and does not reflect a change in the director's outlook on the company.
Positives
- The sale was a routine 'sell-to-cover' transaction to satisfy tax liabilities, rather than a discretionary divestment of holdings.
Negatives
- The transaction represents a reduction in the direct equity stake held by a member of the Board of Directors.
Risks
- Insider selling, even for tax purposes, can sometimes be perceived negatively by retail investors regardless of the underlying intent.
Future Outlook
No forward-looking guidance or strategic outlook was provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that 'sell-to-cover' transactions are standard corporate governance practices for executives and directors to manage tax obligations associated with equity-based compensation plans.
Comparison to Industry Standards
- The transaction aligns with standard industry practices for executive compensation management.
- The volume of shares sold is immaterial relative to the total outstanding shares of the company.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was non-discretionary and small in scale.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 06/11/2026 | Date of the reported stock sale and filing date. |
Keywords
Codexis, CDXS, Insider Trading, Form 4, Equity Compensation, Director Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.